150 results on '"Påhlman, L"'
Search Results
2. What Is the Appropriate Timetable and Exams Density for Tailored Follow-Up?
3. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial
4. Risk of bacteremia in patients presenting with shaking chills and vomiting - a prospective cohort study
5. Radiochemotherapy as an Adjuvant Treatment for Rectal Cancer
6. Respiratory adenovirus infections in immunocompetent and immunocompromised adult patients
7. Role of icodextrin in the prevention of small bowel obstruction. Safety randomized patients control of the first 300 in the ADEPT trial
8. Rectal cancer with synchronous liver metastases: Do we have a clear direction?
9. CT imaging for prediction of complications and recurrence in acute uncomplicated diverticulitis
10. Time trends, improvements and national auditing of rectal cancer management over an 18‐year period
11. Nomograms to predict survival and the risk for developing local or distant recurrence in patients with rectal cancer treated with optional short-term radiotherapy
12. Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial
13. Comparison between MRI and CT in prediction of peritoneal carcinomatosis index (PCI) in patients undergoing cytoreductive surgery in relation to the experience of the radiologist
14. Differences in pre-operative treatment for rectal cancer between Norway, Sweden, Denmark, Belgium and the Netherlands
15. 96. Differences in adjuvant chemotherapy administration for rectal cancer patients - a EURECCA international comparison
16. 27. Differences in adjuvant chemotherapy administration for stage II colon cancer patients – a EURECCA international comparison
17. Impact of mechanical bowel preparation on survival after colonic cancer resection
18. Degree of blood loss during surgery for rectal cancer: a population‐based epidemiologic study of surgical complications and survival
19. Cytoreductive surgery plus perioperative intraperitoneal chemotherapy in pseudomyxoma peritonei: Aspects of the learning curve
20. OC-0251: The value of postoperative chemotherapy for rectal cancer patients after preoperative(chemo)radiotherapy and TME
21. The use of pre- or postoperative antibiotics in surgery for appendicitis: A systematic review
22. Short-term outcome after neoadjuvant high-dose-rate endorectal brachytherapy or short-course external beam radiotherapy in resectable rectal cancer
23. Population-based data from the Swedish Colon Cancer Registry
24. Effect of local gentamicin-collagen on perineal wound complications and cancer recurrence after abdominoperineal resection: a multicentre randomized controlled trial
25. Patients with rectal cancer receiving adjuvant chemotherapy have an increased survival: a population-based longitudinal study
26. 4. Downstaging in rectal cancer
27. 145. Swedish rectal cancer registry – Implications of national auditing on patients' care
28. 149. The EURECCA-project - Analyses of the EURECCA-project
29. Long‐term functional outcome after restorative proctocolectomy in patients with ulcerative colitis
30. European quality assurance programme in rectal cancer - are we ready to launch?
31. The Easy-X magnetic stoma connector system. A future concept for stomal dressing?
32. Treatment strategies for patients with stage IV rectal cancer: A report from the Swedish Rectal Cancer Registry
33. Can acute abdominal CT prioritize patients with suspected diverticulitis for a subsequent clean colonic examination?
34. The EURECCA project: Data items scored by European colorectal cancer audit registries
35. Laparoscopic extraperitoneal rectal cancer surgery: the clinical practice guidelines of the European Association for Endoscopic Surgery (EAES)
36. Growth differentiation factor 15: a prognostic marker for recurrence in colorectal cancer
37. Surgery for rectal cancer (conventional open surgery)
38. Association studies on 11 published colorectal cancer risk loci
39. Sphincter preservation in rectal cancer is associated with patients' socioeconomic status
40. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
41. Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer
42. Multicentre analysis of oncological and survival outcomes following anastomotic leakage after rectal cancer surgery
43. An interim analysis of recruitment to the COLOFOL trial
44. Peritonectomy with high voltage electrocautery generates higher levels of ultrafine smoke particles
45. Commentary
46. Postoperative adverse events and long-term survival after cytoreductive surgery and intraperitoneal chemotherapy
47. Risk factors for anastomotic leakage after rectal cancer surgery: a case-control study
48. Systemic exposure of the parent drug oxaliplatin during hyperthermic intraperitoneal perfusion
49. The prognostic significance of tryptophanyl-tRNA synthetase (trpRS) in colorectal cancer
50. Heterogeneous activity of cytotoxic drugs in patient samples of peritoneal carcinomatosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.